P2RY12 and coronary artery disorder: A meta-analysis of randomized trials investigating P2Y12 inhibitor monotherapy after revascularization suggested that the benefit of P2Y12 inhibitor monotherapy on lower bleeding rates was consistent in subgroup analyses according to complexity of PCI (complex vs. non-complex PCI) and clinical presentation (stable CAD vs. ACS) (35).